Holly Johnson, PhD

The Clinical Utility of Combinatorial Pharmacogenomic Testing for Patients with Depression: A Meta-Analysis

Background: Pharmacogenomic (PGx) testing is a potential tool to inform clinicians’ treatment decisions for patients with Major Depressive Disorder (MDD). However, there is mixed evidence...

Ken Yu , MS;

Holly Johnson , PhD;

Krystal Brown , PhD;

Michael Jablonski , PhD;

Bryan Dechairo , PhD;

Lisa Brown , PhD;

Oliver Vranjkovic , PhD;

James Li , MS, PhD;

10/08/2020

Utilization of Psychiatric Pharmacogenomic Testing by Primary Care Physicians and Advanced Practice Providers: Confidence and Implementation Barriers

Routine implementation of pharmacogenomic testing for mental health and other conditions treated in primary care may require overcoming barriers such as cost to the patient and knowledge ...

Holly Johnson , PhD;

10/26/2023